DSM Capital Partners LLC NBIX Holdings History
DSM Capital Partners LLC's Neurocrine Biosciences Inc Holding Summary
As of 2025-03-31, DSM Capital Partners LLC held - shares of Neurocrine Biosciences Inc(NBIX), totaling N/A. This investment constitutes 0% of their stock portfolio, and DSM Capital Partners LLC now holds 0% of the outstanding Neurocrine Biosciences Inc(NBIX) stock.
The initial trade took place in 2019Q1. And since then DSM Capital Partners LLC has made 9 purchases of NBIX, at an average price of $93.74, for a total of 1.78 Mil shares. In addition, there have been 16 sales at an average price of $118.53 for 1.78 Mil shares. Based on historical transaction data and NBIX's current price of $135.20, DSM Capital Partners LLC's estimated gain on his NBIX holdings is $44.21 Mil, reflecting a 26.44% gain to date.
DSM Capital Partners LLC NBIX ($135.20) Holding Chart
DSM Capital Partners LLC NBIX ($135.20) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
